"A patient's goal of achieving optimal quality of life as a trans person requires respect. The Cass Review, lacking expertise and compromised by implicit stigma and misinformation, does not give credible evidence‐based guidance. We are gravely concerned about its impact on the well-being of trans and gender‐diverse people."
"We are looking at the balance between, possibly, benefits for mental health and quality of life, and any possible risks or harms."
"intrusive and distressing"
Young people under 16 will face 13½ hours of medical assessments before being able to access puberty blockers under a new NHS-commissioned two-year Pathways trial. King's College London will study physical, social and emotional wellbeing in around 220 young teenagers. Participants must complete roughly 50 forms, including questions on trauma and suicide, and undergo bodily examinations. Half of participants will receive treatment immediately; the other half will wait a year for access. The £10 million trial is the only NHS route to obtain puberty blockers following a government ban. Campaigners described the trial as intrusive and distressing.
Read at PinkNews | Latest lesbian, gay, bi and trans news | LGBTQ+ news
Unable to calculate read time
Collection
[
|
...
]